Aromatase and endometriosis: estrogens play a role
Aberrant aromatase expression in endometriosis leads to local estrogen production, which drives inflammation and lesion growth, and is partially targeted by aromatase inhibitors for pain management.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (64)
- A predictive model for endometriosis via openalex
- Aromatase: a key molecule in the pathophysiology of endometriosis and a therapeutic target via openalex
- Aromatase expression in endometriosis via openalex
- Aromatase expression in endometriosis. via openalex
- Aromatase expression in endometriotic tissues and cell cultures of patients with endometriosis via openalex
- Changes in the size of rectovaginal endometriotic nodules infiltrating the rectum during hormonal therapies via openalex
- Characterization of messenger RNA expression of estrogen receptor-α and -β in patients with ovarian endometriosis via openalex
- Comparison of cytokine levels and embryo toxicity in peritoneal fluid in infertile women with untreated or treated endometriosis via openalex
- Detection of aromatase cytochrome P-450 in endometrial biopsy specimens as a diagnostic test for endometriosis via openalex
- Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis via openalex
- Elevated levels of macrophage migration inhibitory factor in the peripheral blood of women with endometriosis via openalex
- Endometrial and Endometriotic Concentrations of Estrone and Estradiol Are Determined by Local Metabolism Rather than Circulating Levels via openalex
- Endometriosis via openalex
- Endometriosis in menopause: a single institution experience via openalex
- Estrogen and progesterone receptor expression in macrophages and regulation of hepatocyte growth factor by ovarian steroids in women with endometriosis via openalex
- Expression of Aromatase Cytochrome P450 Protein and Messenger Ribonucleic Acid in Human Endometriotic and Adenomyotic Tissues but not in Normal Endometrium1 via openalex
- Expression of estrogen receptor alpha and beta in peritoneal and ovarian endometriosis via openalex
- Expression of oestrogen receptor-alpha and -beta in ovarian endometriomata via openalex
- Future Perspectives in the Medical Treatment of Endometriosis via openalex
- GnRH analogue remarkably down-regulates inflammatory proteins in peritoneal fluid proteome of women with endometriosis. via openalex
- Gonadotropin-releasing hormone agonist treatment for endometriosis of the rectovaginal septum via openalex
- Increased chemotactic activity of peritoneal fluid in patients with endometriosis via openalex
- Involvement of estrogen receptor-related receptors in human ovarian endometriosis via openalex
- Letrozole and desogestrel‐only contraceptive pill for the treatment of stage IV endometriosis via openalex
- Letrozole and norethisterone acetate in colorectal endometriosis via openalex
- Letrozole and norethisterone acetate in rectovaginal endometriosis via openalex
- Macrophage migration inhibitory factor expression in the intrauterine endometrium of women with endometriosis varies with disease stage, infertility status, and pelvic pain via openalex
- Macrophage Migration Inhibitory Factor Is Involved in a Positive Feedback Loop Increasing Aromatase Expression in Endometriosis via openalex
- Macrophages are activated by 17b-estradiol: possible permission role in endometriosis via openalex
- Marked elevation of macrophage migration inhibitory factor in the peritoneal fluid of women with endometriosis via openalex
- Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity via openalex
- Pharmacological Treatment of Endometriosis via openalex
- Postmenopausal Endometrioma and Hormonal Replacement Therapy via openalex
- Prevalence of newly diagnosed endometriosis in women attending the general practitioner via openalex
- Promoter Methylation Regulates Estrogen Receptor 2 in Human Endometrium and Endometriosis1 via openalex
- Prostaglandin E2 Via Steroidogenic Factor-1 Coordinately Regulates Transcription of Steroidogenic Genes Necessary for Estrogen Synthesis in Endometriosis via openalex
- Prostaglandin F2 alpha and E2 release by peritoneum with and without endometriosis. via openalex
- Quantitative analysis of estrogen receptor alpha and beta messenger ribonucleic acid levels in normal endometrium and ovarian endometriotic cysts using a real-time reverse transcription-polymerase chain reaction assay via openalex
- Reduction of the intraperitoneal inflammation associated with endometriosis by treatment with medroxyprogesterone acetate via openalex
- Retrograde menstruation in healthy women and in patients with endometriosis. via openalex
- Return of Chronic Pelvic Pain From Endometriosis After Raloxifene Treatment via openalex
- Role of Estrogen Receptor-β in Endometriosis via openalex
- Role of Estrogens in Inflammatory Response via openalex
- Role of the vaginally administered aromatase inhibitor anastrozole in women with rectovaginal endometriosis: a pilot study via openalex
- [Study on expression of estrogen receptor isoforms in eutopic and ectopic endometrium of ovarian endometriosis]. via openalex
- Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. via openalex
- W2033465412 via openalex
- W2154377312 via openalex
- W2028959957 via openalex
- W2159803441 via openalex
- W2021918003 via openalex
- W2000630313 via openalex
- W1967192396 via openalex
- W1966609815 via openalex
- W2416855537 via openalex
- W4255841728 via openalex
- W2103212783 via openalex
- W2087037893 via openalex
- W2109525253 via openalex
- W2086645076 via openalex
- W2066865081 via openalex
- W2126100083 via openalex
- W2146098026 via openalex
- W2152793184 via openalex
Cited by (50)
- The Microbiota–Endometriosis Axis: An Immune–Endocrine Integration Model and Emerging Therapeutic Targets 2026
- Virtual screening of Dioscorea alata active compound in the Sphingolipid metabolic pathway in endometriosis-related genes 2025
- Comparison of Pregnancy Outcomes and Vaginal Microbiota in Endometriosis Patients Undergoing Frozen Embryo Transfer Using Letrozole Combined HMG Versus Hormone Replacement Therapy with GnRH-a Pretreatment 2025
- Urinary Tract Endometriosis: A Review of Literature 2024
- Consider fertility-preserving medications when treating adenomyosis 2024
- Role of the gut microbiota in the pathogenesis of endometriosis: a review 2024
- The Impacts of Inflammatory and Autoimmune Conditions on the Endometrium and Reproductive Outcomes 2024
- The “Road” to Malignant Transformation from Endometriosis to Endometriosis-Associated Ovarian Cancers (EAOCs): An mTOR-Centred Review 2024
- Gene expression of aromatase, SF-1, and HSD17B2 in menstrual blood as noninvasive diagnostic biomarkers for endometriosis 2024
- Establishment of Immortalized Human Endometriotic Stromal Cell Line from Ectopic Lesion of a Patient with Endometriosis 2023
- A review of phase II and III drugs for the treatment and management of endometriosis 2023
- Extensive heterogeneity in the expression of steroid receptors in superficial peritoneal endometriotic lesions 2023
- A Systematic Review of Systematic Reviews on the Use of Aromatase Inhibitors for the Treatment of Endometriosis: The Evidence to Date 2023
- Tratamento clínico de endometriose profunda com uso de droga antiproliferativa (metotrexato) acoplado a nanoemulsão lipídica (LDE) 2023
- The gut microbiota and endometriosis: From pathogenesis to diagnosis and treatment 2022
- Pain 2021
- Phytoestrogens for the Management of Endometriosis: Findings and Issues 2021
- Role of medical treatment of endometriosis 2021
- Potential Therapeutic Options and Perspectives for Alleviation of Endometrial Estrogen Dominance and Progesterone Resistance in Endometriosis 2021
- Endometriosis - Recent Advances, New Perspectives and Treatments 2021
- Molecular dysregulations underlying the pathogenesis of endometriosis 2021
- Establishment of an immortalized stromal cell line derived from human Endometriotic lesion 2020
- Endometriosis Associated Infertility: A Critical Review and Analysis on Etiopathogenesis and Therapeutic Approaches 2020
- Brassica Bioactives Could Ameliorate the Chronic Inflammatory Condition of Endometriosis 2020
- Detection of endometriosis using immunocytochemistry of P450 Aromatase expressions in eutopic endometrial cells obtained from menstrual sloughing: A diagnostic study 2020
- Detection of endometriosis using immunocytochemistry of P450 Aromatase expressions in eutopic endometrial cells obtained from menstrual sloughing: a diagnostic study 2020
- Epidemiological profile of women with endometriosis: a retrospective descriptive study 2020
- <p>Effects of long-term treatment with Dienogest on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain</p> 2019
- Progesterone Resistance and Adult Stem Cells’ Genomic and Epigenetic Changes in the Puzzle of Endometriosis 2019
- Hormones and Inflammation: An Update on Endometriosis 2019
- Future directions in endometriosis treatment: discovery and development of novel inhibitors of estrogen biosynthesis 2019
- A comprehensive review of hormonal and biological therapies for endometriosis: latest developments 2019
- Tratamientos farmacológicos de la endometriosis (a excepción de la adenomiosis) 2018
- Investigational drugs for the treatment of endometriosis, an update on recent developments 2018
- Silibinin‐induced endoplasmic reticulum stress and mitochondrial dysfunction suppress growth of endometriotic lesions 2018
- SULFATION PATHWAYS: Contribution of intracrine oestrogens to the aetiology of endometriosis 2018
- The Clinical and Experimental Research on the Treatment of Endometriosis with Thiostrepton 2018
- Notch activity mediates oestrogen-induced stromal cell invasion in endometriosis 2018
- Meningioma en gestante afecta de endometriosis profunda. A propósito de un caso 2018
- Current and emerging treatment options for endometriosis 2018
- Current and Emerging Therapeutics for the Management of Endometriosis 2018
- Current understanding on pharmacokinetics, clinical efficacy and safety of progestins for treating pain associated to endometriosis 2018
- Prospects of metformin in the treatment of endometriosis 2017
- Investigation of anogenital distance as a diagnostic tool in endometriosis 2017
- Evaluation of two endometriosis models by transplantation of human endometrial tissue fragments and human endometrial mesenchymal cells 2017
- Estrogen is an important mediator of mast cell activation in ovarian endometriomas 2017
- Role of Brain-Derived Neurotrophic Factor in Endometriosis Pain 2017
- Traitement médical de l’endométriose : prise en charge de la douleur et de l’évolution des lésions par traitement hormonal et perspectives thérapeutiques 2017
- Progesterone Alleviates Endometriosis via Inhibition of Uterine Cell Proliferation, Inflammation and Angiogenesis in an Immunocompetent Mouse Model 2016
- Smad3/4 Binding to Promoter II of P450arom So As to Regulate Aromatase Expression in Endometriosis 2016
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:18:29.016410+00:00